| 2841 |
Bevacimab
|
Bevacizumab
|
IV Infusion |
100 mg/4 ml |
0.00 |
| 2842 |
Bevaris
|
Bevacizumab
|
IV Infusion |
100 mg/4 ml |
0.00 |
| 2843 |
Bevaris
|
Bevacizumab
|
IV Infusion |
400 mg/16 ml |
0.00 |
| 2844 |
Bevastim
|
Bevacizumab
|
IV Infusion |
100 mg/4 ml |
0.00 |
| 2845 |
Bevastim
|
Bevacizumab
|
IV Infusion |
400 mg/16 ml |
0.00 |
| 2846 |
Bevicort
|
Formoterol Fumarate + Glycopyrrolate + Budesonide
|
Metered-Dose Inhaler (MDI) |
(5.5 mcg+10.4 mcg+182 mcg)/actuation |
0.00 |
| 2847 |
Beviprex
|
Glycopyrronium Bromide + Formoterol Fumarate
|
Metered-Dose Inhaler (MDI) |
(9 mcg+4.8 mcg)/puff |
0.00 |
| 2848 |
Bevit
|
Vitamin B complex
|
Tablet |
5 mg+2 mg+2 mg+20 mg |
0.43 |
| 2849 |
Bevixa
|
Bevacizumab
|
IV Infusion |
100 mg/4 ml |
0.00 |
| 2850 |
Bevixa
|
Bevacizumab
|
IV Infusion |
400 mg/16 ml |
0.00 |
| 2851 |
Bexidal
|
Mebhydrolin Napadisylate
|
Tablet |
50 mg |
3.00 |
| 2852 |
Bexihaler
|
Inhaler device
|
Metered-Dose Inhaler (MDI) |
N/A |
0.00 |
| 2853 |
Bexipred
|
Prednisolone Acetate
|
Ophthalmic Suspension |
1% |
0.00 |
| 2854 |
Bexitrol F
|
Salmeterol + Fluticasone Propionate
|
Multidose Dry Powder Inhaler (MDPI) |
50 mcg+250 mcg |
0.00 |
| 2855 |
Bexitrol F
|
Salmeterol + Fluticasone Propionate
|
Metered-Dose Inhaler (MDI) |
(25 mcg+125 mcg)/puff |
0.00 |
| 2856 |
Bexitrol F
|
Salmeterol + Fluticasone Propionate
|
Metered-Dose Inhaler (MDI) |
(25 mcg+50 mcg)/puff |
0.00 |
| 2857 |
Bexitrol F
|
Salmeterol + Fluticasone Propionate
|
Multidose Dry Powder Inhaler (MDPI) |
50 mcg+500 mcg |
0.00 |
| 2858 |
Bexitrol F
|
Salmeterol + Fluticasone Propionate
|
Multidose Dry Powder Inhaler (MDPI) |
50 mcg+100 mcg |
0.00 |
| 2859 |
Bexitrol F
|
Salmeterol + Fluticasone Propionate
|
Dry Powder Inhalation Capsule (DPI) |
50 mcg+500 mcg |
17.00 |
| 2860 |
Bexitrol F
|
Salmeterol + Fluticasone Propionate
|
Dry Powder Inhalation Capsule (DPI) |
50 mcg+250 mcg |
12.00 |
